Enzymatic technology for the production of enantiopure chiral amines and amino acids
Ingenza's operates proprietary chemo-enzymatic and biocatalytic technology platforms to produce chiral amines and unnatural amino acids at >99.9 % enantiomeric excess and in high yield. The methods have been applied to a diverse range of industrially relevant target compounds using biocatalysts which have been adapted towards selected targets by directed evolution and improved to meet requirements of industrial operation. These processes are now being implemented as highly competitive routes at manufacturing scale.
Benefits of Ingenza's biocatalytic technology
- Single enantiomers in high yield from low cost starting materials including racemic mixtures
- Applicable to major chiral compound families - amino acids, amines
- Appropriate for large scale
- Adaptable to new targets by directed evolution of oxidase biocatalysts
- Cost effective and efficient manufacture
